Garda to Acquire Assertio in $125M Pharma Deal
LAKE FOREST, Ill., April 8, 2026 Assertio Holdings, Inc. has entered into a definitive agreement to be acquired by...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
LAKE FOREST, Ill., April 8, 2026 Assertio Holdings, Inc. has entered into a definitive agreement to be acquired by...
MILAN, Italy, March 26, 2026 Recordati S.p.A. has confirmed receiving a non-binding indication of interest from CVC Capital Partners...
INDIANAPOLIS, USA & BOSTON, USA & LONDON, UK, March 31, 2026 Eli Lilly and Company has announced a definitive...
DUBLIN, Feb. 12, 2026 — Alkermes plc has completed its acquisition of Avadel Pharmaceuticals plc, accelerating its strategic entry...
New York, October 30, 2025 — Pfizer Inc. (NYSE: PFE) has issued a strong response to what it calls...
